GSK scandal ensnares Shanghai official as China probe widens
This article was originally published in SRA
Executive Summary
Ongoing investigations into alleged bribery in the pharmaceutical industry in China appear to be expanding from private companies into the realm of government officials, recent developments in Shanghai suggest.